A test for a wide range of genetic risk factors could improve doctors’ ability to work out which women are at increased risk of developing breast cancer, a major study of more than 65,000 women has shown.
Discovery could offer a new target for treatment of glioblastoma.
Moffitt Cancer Center researchers discovered a novel mechanism that plays an important role in the maintenance of lung cancer stem cells. This finding may lead to new potential therapeutic targets.
The first personalized cancer vaccine using genomics to define targets elicits robust immune responses, says a recent Science study.
Acoustic device can rapidly isolate circulating tumor cells from patient blood samples.
New therapy approach goes directly to the source of cancer development.
The body's immune system fights disease, infections and even cancer, acting like foot soldiers to protect against invaders and dissenters.
Fasting in combination with chemotherapy has already been shown to kill cancer cells, but a pair of new studies in mice suggests that a less-toxic class of drugs combined with fasting may kill breast, colorectal and lung cancer cells equally well.
Imaging tests like mammograms or CT scans can detect tumors, but figuring out whether a growth is or isn’t cancer usually requires a biopsy to study cells directly.
A new study found that people with lower vitamin D levels prior to treatment for follicular lymphoma succumb to the disease or face relapse earlier than patients with sufficient vitamin D levels in their blood.
Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine presages an era of increased understanding of the molecular basis of cancer and of the ability to design treatments tailored to a patient’s own genetic profile, a panel of experts said.
Results of a study suggest that MRI could one day make biopsies more effective or even replace them altogether by noninvasively detecting telltale sugar molecules shed by the outer membranes of cancerous cells.
Immune system response isn't as crucial as activity of the infected cells themselves.
Scientists at UCLA’s California NanoSystems Institute and Jonsson Comprehensive Cancer Center have combined their nanotechnology expertise to create a new treatment that may solve some of the problems of using chemotherapy to treat pancreatic cancer.
The biotech firm is making a big bet on precision medicine.
New labeling on the world's most popular weed killer as a likely cause of cancer is raising more questions for an aerial spraying program in Colombia that underpins U.S.-financed efforts to wipe out cocaine crops.
Deadly familial stomach and lobular breast cancers could be successfully treated at their earliest stages, or even prevented, by existing drugs that have been newly identified by University of Otago cancer genetics researchers.
A Harvard University and Waterloo University team has found that a common breast cancer chemotherapy (chemo) can create stem-like cancer cells out of more differentiated tumor cells.
Highly sensitive genomic analysis of acute lymphoblastic leukemia cells reveals for the first time how the malignant cells evolve to cause relapse.
Obese women have around a 40 percent greater risk of developing a weight-related cancer in their lifetime than women of a healthy weight, according to new figures* released by Cancer Research UK Tuesday.
The human gut is a remarkable thing. Every week the intestines regenerate a new lining, sloughing off the equivalent surface area of a studio apartment and refurbishing it with new cells. This year researchers figured out a way to isolate and grow thousands of these elusive cells in the laboratory at one time.
Mental training exercises developed at the Jonsson Comprehensive Cancer Center have been shown to help mitigate the effects of "chemo brain"
Scientists from the Florida campus of The Scripps Research Institute (TSRI) have confirmed the ribosome assembly process as a potentially fertile new target for anti-cancer drugs by detailing the essential function of a key component in the assembly process.
After a chance observation in the lab, researchers found a method that can force dangerous leukemia cells in the lab to mature into harmless immune cells called macrophages.